The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(5-chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)-3-azaspiro[5.5]undecan-9-yl)acetic acid ID: ALA3937916
PubChem CID: 117886639
Max Phase: Preclinical
Molecular Formula: C22H30ClNO3
Molecular Weight: 391.94
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)Cc2cc(Cl)cc(N3CCC4(CCC(CC(=O)O)CC4)CC3)c2O1
Standard InChI: InChI=1S/C22H30ClNO3/c1-21(2)14-16-12-17(23)13-18(20(16)27-21)24-9-7-22(8-10-24)5-3-15(4-6-22)11-19(25)26/h12-13,15H,3-11,14H2,1-2H3,(H,25,26)
Standard InChI Key: NUGWEZBZPNGBKL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
14.8706 -5.5434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1643 -5.9565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8752 -6.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4661 -5.5555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7495 -5.1452 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12.8842 -10.5049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1817 -7.6140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1835 -5.1382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8733 -12.1572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1611 -11.7393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8944 -8.8567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8674 -12.9830 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4560 -10.4951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8906 -9.6777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1670 -10.9135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4691 -8.8567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1817 -6.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5913 -11.7494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8944 -8.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1780 -9.2654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4691 -8.0310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4607 -9.6741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4693 -6.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8992 -5.5519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9022 -6.3738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6848 -6.6249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6800 -5.2952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
10 9 1 0
13 15 1 0
8 4 1 0
17 25 2 0
6 14 1 0
22 13 1 0
20 11 1 0
20 22 1 0
9 18 1 0
16 20 1 0
4 5 1 0
21 7 1 0
19 7 1 0
15 10 1 0
20 14 1 0
7 17 1 0
11 19 1 0
15 6 1 0
9 12 2 0
23 17 1 0
24 8 2 0
21 16 1 0
4 23 2 0
24 25 1 0
25 26 1 0
26 2 1 0
2 27 1 0
27 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.94Molecular Weight (Monoisotopic): 391.1914AlogP: 5.31#Rotatable Bonds: 3Polar Surface Area: 49.77Molecular Species: ACIDHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.70CX Basic pKa: 2.76CX LogP: 4.87CX LogD: 2.33Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: 0.06
References 1. Cox JM, Chu HD, Chelliah MV, Debenham JS, Eagen K, Lan P, Lombardo M, London C, Plotkin MA, Shah U, Sun Z, Vaccaro HM, Venkatraman S, Suzuki T, Wang N, Ashley ER, Crespo A, Madeira M, Leung DH, Alleyne C, Ogawa AM, Souza S, Thomas-Fowlkes B, Di Salvo J, Weinglass A, Kirkland M, Pachanski M, Powles MA, Tozzo E, Akiyama TE, Ujjainwalla F, Tata JR, Sinz CJ.. (2017) Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists., 8 (1): [PMID:28105274 ] [10.1021/acsmedchemlett.6b00360 ]